Response to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study

REFERENCES

• Fisher B., Bryant J., Wolmark N., Mamounas E., Brown A., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J. Clin. Oncol. 1998; 16(8)2672–2685, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bonadonna G., Valagussa P., Brambilla C., Ferrari L., Moliterni A., et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J. Clin. Oncol. 1998; 16(1)93–100, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Scholl S. M., Pierga J. Y., Asselain B., Beuzeboc P., Dorval T., et al. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur. J. Cancer. 1995; 31A(12)1969–1975, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Scholl S. M., Beuzeboc P., Haris A. L., Pierga J. Y., Asselain B., et al. Is primary chemotherapy useful for all patients with primary invasive breast cancer?. Recent Results Cancer Res. 1998; 152: 217–226, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hickman J. A., Beere H. M., Wood A. C., Waters C. M., Parmar R. Mechanisms of cytotoxicity caused by antitumour drugs. Toxicol Lett. 1992; 64–65: 553–561, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ohmori T., Podack E. R., Nishio K., Takahashi M., Miyahara Y., et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem. Biophys. Res. Commun. 1993; 192(1)30–36, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Walton M. I., Whysong D., O'Connor P. M., Hockenbery D., Korsmeyer S. J., Kohn K. W. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res. 1993; 53(8)1853–1861, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hagg M., Biven K., Ueno T., Rydlander L., Bjorklund P., Wiman K. G., Shoshan M., Linder S. A novel high-through-put assay for screening of pro-apoptotic drugs. Invest New Drugs. 2002; 20(3)253–259, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Meyn R. E., Stephens L. C., Hunter N. R., Milas L. Apoptosis in murine tumors treated with chemotherapy agents. Anticancer Drugs. 1995; 6(3)443–450, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ellis P. A., Smith I. E., McCarthy K., Detre S., Salter J., Dowsett M. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet. 1997; 349(9055)849, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Caulin C., Salvasen G. S., Oshima R. G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. Cell Biol. 1997; 138(6)1379–1394, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ku N. O., Liao J., Omary M. B. Apoptosis generates stable fragments of human type I keratins. J Biol Chem. 1997; 272(52)33197–33203, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• MacFarlane M., Merrison W., Dinsdale D., Cohen G. M. Active caspase sand cleaved cytokeratins ae sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J Cell Biol. 2000; 148(6)1239–1254, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Leers M. P., Kolgen W., Bjorklund V., Bergman T., Tribbick G., Persson B., Bjorklund P., Ramaekers F. C., Bjorklund B., Nap M., Jornvall H., Schutte B. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol. 1999; 187(5)567–572, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kramer G, Erdal H, Mertens H J, Nap M, Mauermann J, Steiner G, Marberger M, Biven K, Shoshan M C, Linder S. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004; 64(5)1751–1756, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ueno T., Toi M., Biven K., Bando H., Ogava T., Linder S. Measurement of an apoptotic product in the sera of breast cancer patients. Eur J Cancer. 2003; 39(6)769–774, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Biven K., Erdal H., Hagg M., Ueno T., Zhou R., Lynch M., Rowley B., Wood J., Zhang C., Toi M., Shoshan M. C., Linder S. A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera. Apoptosis. 2003; 8(3)263–268, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kerr J. F., Winterford C. M., Harmon B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994; 73(8)2013–2026, [CSA]
   PubMed Web of Science ®Google Scholar
• Wijsman J. H., Jonker R. R., Keijzer R., van de Velde C. J., Cornelisse C. J., van Dierendonck J. H. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 1993; 41(1)7–12, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992; 119(3)493–501, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chiu P. M., Ngan Y. S., Khoo U. S., Cheung A. N. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology. 2001; 38(3)243–249, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Archer C. D., Patron M., Smith I. E., Ellis P. A., Salter J., Ashley S., Gui G., Sacks N., Ebbs S. R., Allum W., Nasiri N., Dowsett M. Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer. Br J Cancer. 2003; 89(6)1035–1041, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Buchholz T. A., Davis D. W., McConkey D. J., Symmans W. F., Valero V., Jhingran A., Tucker S. L., Pusztai L., Cristofanilli M., Esteva F. J., Hortobagyi G. N., Sahin A. A. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J. 2003; 9(1)33–41, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chang J., Ormerod M., Powles T. J., Allred D. C., Ashley S. E., Dowsett M. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer. 2000; 89(11)2145–2152, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Davis D. W., Buchholz T. A., Hess K. R., Sahin A. A., Valero V., McConkey D. J. Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response. Clin Cancer Res. 2003; 9(3)955–960, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Stearns V., Singh B., Tsangaris T., Crawford J. G., Novielli A., Ellis M. J., Isaacs C., Pennanen M., Tibery C., Farhad A., Slack R., Hayes D. F. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Clin Cancer Res. 2003; 9(1)124–33, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Colleoni M., Minchella I., Mazzarol G., Nole F., Peruzzotti G., Rocca A., Viale G., Orlando L., Ferretti G., Curigliano G., Veronesi P., Intra M., Goldhirsch A. Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors. Ann Oncol. 2000; 11(8)1057–1059, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Colleoni M., Gelber S., Coates A. S., Castiglione-Gertsch M., Gelber R. D., Price K., Rudenstam C. M., Lindtner J., Collins J., Thurlimann B., Holmberg S. B., Cortes-Funes H., Simoncini E., Murray E., Fey M., Goldhirsch A., International Breast Cancer Study Group. Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer. J Clin Oncol. 2001; 19(21)4141–4149, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• MacGrogan G., Mauriac L., Durand M., Bonichon F., Trojani M., de Mascarel I., Coindre J. M. Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi. Br J Cancer. 1996; 74(9)1458–1465, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bonadonna G., Veronesi U., Brambilla C., Ferrari L., Luini A., Greco M., Bartoli C., Coopmans de Yoldi G., Zucali R., Rilke F. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst. 1990; 82(19)1539–1545, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lipponen P., Aaltomaa S., Kosma V. M., Syrjanen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer. 1994; 30A(14)2068–2073, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mustonen M., Raunio H., Paakko P., Soini Y. The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions. Histopathology. 1997; 31(4)347–354, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bear H. D., Anderson S., Smith R. E., Robidoux A., Kahlenberg M. S., Margolese R. G., Dakhil S. R., Pajon E. R., Hoehn J. L., Mamounas E. P., Geyer C. E., Julian T. B., Wolmark N. A randomized trial comparing preoperative (preop) doxorubicin/cyclophosphamide (AC) to preop AC followed by preop docetaxel (T) and to preop AC followed by postoperative (postop) T in patients (pts) with operable carcinoma of the breast: results of NSABP B-27. Breast Cancer Res. Treat. 2004; 88(2)16, (Abstr 26)[CSA]
   Google Scholar